Valuation: Ipca Laboratories Limited

Market Cap 456B 4.78B 4.14B 3.88B 3.54B 6.66B 6.76B 45.69B 17.84B 228B 17.93B 17.54B 761B P/E 2027 *
32.7x
P/E 2028 * 27.4x
Enterprise Value 444B 4.65B 4.03B 3.78B 3.45B 6.48B 6.59B 44.5B 17.37B 222B 17.46B 17.08B 741B EV / Sales 2027 *
4.12x
EV / Sales 2028 * 3.6x
Free-Float
54.94%
Yield 2027 *
0.32%
Yield 2028 * 0.35%
1 day+1.68%
1 week+1.77%
Current month+2.77%
1 month+0.47%
3 months+19.03%
6 months+21.96%
Current year+26.60%
1 week 1,674.4
Extreme 1674.4
1,905
1 month 1,674.4
Extreme 1674.4
1,944.9
Current year 1,391.8
Extreme 1391.8
1,944.9
1 year 1,251.6
Extreme 1251.6
1,944.9
3 years 847.3
Extreme 847.3
1,944.9
5 years 669.8
Extreme 669.8
1,944.9
10 years 200
Extreme 200
1,944.9
Manager TitleAgeSince
Chief Executive Officer 53 2023-03-31
Chief Executive Officer 70 2023-03-31
Chief Tech/Sci/R&D Officer 52 2023-10-15
Director TitleAgeSince
Chairman 79 2012-07-04
Director/Board Member 53 2008-11-10
Director/Board Member 70 1994-07-31
Date Insider Type Main position Quantity % Market Cap.
12/19/24 Sell 4,000,000 1.5766%
Change 5-day change 1-year change 3-year change Capi.($)
+1.68%+1.77%+30.48%+98.04% 4.7B
-0.92%+3.35%+89.07%+128.86% 1,088B
+0.47%+1.74%+51.68%+50.75% 629B
+0.83%+1.88%+26.27%+64.82% 440B
-0.88%-0.66%+47.04%+36.64% 359B
-0.37%-0.58%+28.59%+36.31% 291B
+0.05%-2.73%+5.61%+6.15% 245B
+0.40%+2.45%+46.62%+59.17% 225B
-0.42%+1.34%-6.94%-51.94% 204B
+1.67%+4.84%+15.10%+72.68% 168B
Average +0.25%+1.15%+33.35%+50.15% 365.39B
Weighted average by Cap. -0.13%+1.92%+49.06%+66.01%

Financials

2027 *2028 *
Net sales 108B 1.13B 978M 917M 836M 1.57B 1.6B 10.8B 4.21B 53.91B 4.24B 4.14B 180B 120B 1.26B 1.09B 1.02B 932M 1.75B 1.78B 12.04B 4.7B 60.11B 4.72B 4.62B 201B
Net income 14B 147M 127M 119M 109M 204M 208M 1.4B 548M 7.01B 551M 539M 23.38B 16.7B 175M 152M 142M 130M 244M 248M 1.67B 653M 8.36B 657M 643M 27.88B
Net Debt -11.82B -124M -107M -101M -91.79M -173M -175M -1.19B -463M -5.92B -465M -455M -19.74B -23.66B -248M -215M -201M -184M -346M -351M -2.37B -926M -11.84B -931M -911M -39.51B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
26-08-13 ₹1,796.30 +1.68% 1,835,473
26-08-12 ₹1,766.60 +1.04% 149,151
26-08-11 ₹1,748.40 +3.71% 233,132
26-08-10 ₹1,685.80 -2.88% 239,283
26-08-07 ₹1,735.80 +0.09% 79,829
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,796.30INR
Average target price
1,733.50INR
Spread / Average Target
-3.50%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IPCALAB Stock